On the HCPLive Hepatitis C page, resources on the topics of medical news and expert insight into HCV can be found. Content includes articles, interviews, videos, podcasts, and breaking news on hepatitis C virus research, treatment, and drug development.
February 6th 2025
Findings suggest the value of genotyping and histological assessment for guiding HCC screening decisions in patients with chronic HBV.
Direct-Acting Antivirals Reduce Iron Parameters in Patients with HCV, Hyperferritinemia
January 2nd 2024Statistically significant reductions in serum ferritin, transferrin saturation index, and iron levels were observed after treatment, with hyperferritinemia eradicated in nearly all patients treated with DAAs achieving SVR.
Active Use of Patient Portal Associated with Reduced Risk of Readmission, Study Finds
December 23rd 2023More than half of study participants were enrolled in the patient portal and 98% were classified as passive users, but only moderately active use of the patient portal was associated with a reduced risk of readmission.
HCV Screening, Care Model Intervention Improve Patient Outcomes
December 15th 2023Patients with HCV who underwent automated routine screening and the addition of a clinical pharmacist to the interdisciplinary patient care model completed treatment and achieved SVR at a greater rate than patients who were not exposed to the study intervention.
From NAFLD to MASLD: 2023 Brings New Liver Disease Nomenclature
December 13th 2023Following years of concerns about the stigmatization and inaccurate etiology of nonalcoholic fatty liver disease nomenclature, 2023 finally saw revised terminology for liver disease with the implementation of metabolic dysfunction-associated steatotic liver disease.
Study Finds High Hepatitis C Infection Seroprevalence in Pregnant Women
December 8th 2023The seroprevalence of HCV antibody among pregnant women was significantly greater among those with opioid use disorder and HIV infection, as well as in lower-middle-income countries and those with low levels of HDI.
Study Details Ultrasound Prevalence, Clinical Features of NAFLD in Patients with IBD
November 29th 2023The ultrasound prevalence of NAFLD was 23% among a cohort of patients with IBD, with study results further identifying several clinical characteristics associated with IBD-NAFLD including age, gender, BMI, and waist circumference.
Pegozafermin Shows Sustained Benefit for NASH in Phase 2b Extension Study
November 27th 2023Results from the 24-week extension period of the phase 2b ENLIVEN trial showed sustained improvements in liver fat, fibrosis, and inflammation among those treated with 30 mg weekly and 44 mg biweekly pegozafermin.